Soluble mutant huntingtin drives early human pathogenesis in Huntington's disease.

MLA

Miguez, Andrés, et al. “Soluble Mutant Huntingtin Drives Early Human Pathogenesis in Huntington’s Disease.” Cellular and Molecular Life Sciences : CMLS, vol. 80, no. 8, Aug. 2023, p. 238. EBSCOhost, https://doi.org/10.1007/s00018-023-04882-w.

APA

Miguez, A., Gomis, C., Vila, C., Monguió-Tortajada, M., Fernández-García, S., Bombau, G., Galofré, M., García-Bravo, M., Sanders, P., Fernández-Medina, H., Poquet, B., Salado-Manzano, C., Roura, S., Alberch, J., Segovia, J. C., Allen, N. D., Borràs, F. E., & Canals, J. M. (2023). Soluble mutant huntingtin drives early human pathogenesis in Huntington’s disease. Cellular and Molecular Life Sciences : CMLS, 80(8), 238. https://doi.org/10.1007/s00018-023-04882-w

Chicago

Miguez, Andrés, Cinta Gomis, Cristina Vila, Marta Monguió-Tortajada, Sara Fernández-García, Georgina Bombau, Mireia Galofré, et al. 2023. “Soluble Mutant Huntingtin Drives Early Human Pathogenesis in Huntington’s Disease.” Cellular and Molecular Life Sciences : CMLS 80 (8): 238. doi:10.1007/s00018-023-04882-w.